Effector and regulatory events during natural killer-dendritic cell interactions

Immunological Reviews

Volumn 214, Issue 1, 2006, Pages 219-228

  Moretta, Lorenzo ^a,b   Ferlazzo, Guido ^c   Bottino, Cristina ^a   Vitale, Massimo ^d   Pende, Daniela ^d   Mingari, Maria Cristina ^b,d   Moretta, Alessandro ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Dendritic cells; Inflammation; Innate immunity; Natural killer cells

Indexed keywords

ALPHA INTERFERON; CD16 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; IMATINIB; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

ALLOIMMUNITY; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CYTOKINE RELEASE; CYTOMEGALOVIRUS; DENDRITIC CELL; DERMATITIS; ECZEMA; GASTROINTESTINAL STROMAL TUMOR; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LICHENOID ERUPTION; LYMPH NODE; LYMPHOID ORGAN; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TH1 CELL;

ANIMALS; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL;

EID: 33750689486     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2006.00450.x     Document Type: Review

References (111)

1. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993;11:613-635.
2. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A. Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994;55:341-380.
3. Moretta A, et al. Receptors for HLA-class I molecules in human natural killer cells. Annu Rev Immunol 1996;14:619-648.
4. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002;20:217-251.
5. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
6. Cosman D, et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997;7:273-282.
7. Braud VM, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
8. Lopez-Botet M, Carretero M, Bellon T, Perez-Villar JJ, Llano M, Navarro F. Structure and function of the CD94 C-type lectin receptor complex involved in the recognition of HLA-class I molecules. Immunol Rev 1997;155:165-174.
9. Moretta A, et al. Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
10. Tomasello E, Blery M, Vely F, Vivier E. Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells. Semin Immunol 2000;12:139-147.
11. Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands for activating NK receptors. Trends Immunol 2005;26:221-226.
12. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004;23:255-259.
13. Fernandez NC, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999;5:405-411.
14. Della Chiesa M, Sivori S, Castriconi R, Marcenaro E, Moretta A. Pathogen induced-private conversations between natural killer and dendritic cells. Trends Microbiol 2005;13:128-136.
15. Moretta A, Marcenaro E, Sivori S, Della Chiesa M, Vitale M, Moretta L. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol 2005;26:668-675.
16. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol 2004;25:47-52.
17. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 2002;195:9-14.
18. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002;2:957-965.
19. Wilson JL, Heffler LC, Charo J, Scheynius A, Bejarano MT, Ljunggren HG. Targeting of human dendritic cells by autologous NK cells. J Immunol 1999;163:6365-6370.
20. Carbone E, et al. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 1999;29:4022-4029.
21. Spaggiari GM, et al. NK cell-mediated lysis of autologous antigen presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 2001;31:1656-1665.
22. Ferlazzo G, Tsang M-L, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195:343-351.
23. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between NK cells and dendritic cells. J Exp Med 2002;195:327-333.
24. Piccioli D, Sbrana S, Melandri E, Valiante N-M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195:335-341.
25. Pende D, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999;190:1505-1516.
26. Costello RT, et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002;99:3661-3667.
27. Fauriat C, Moretta A, Olive D, Costello RT. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. Blood 2005;106:2186-2188.
28. Castriconi R, et al. TGFb1 inhibits expression of the NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci USA 2003;100:4120-4125.
29. Pende D, et al. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 2006;107:2030-2036.
30. Bottino C, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003;198:557-567.
31. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002;3:6-8.
32. Ljunggren H-G, Karre K. In search of the "missing self". MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
33. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003;33:1657-1666 [Erratum in Eur J Immunol 2003;33:2947].
34. Ferlazzo G, et al. The interaction between natural killer and dendritic cell in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003;33:306-313.
35. Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 1999;189:611-614.
36. Banchereau J, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
37. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
38. Reis e Sousa C. Dendritic cells as sensors of infection. Immunity 2001;14:495-498.
39. Mingari MC, et al. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol 1995;7:697-703.
40. Pietra G, Romagnani C, Mazzarino P, Millo E, Moretta L, Mingari MC. Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells. Eur J Immunol 2003;33:3427-3432.
41. Romagnani C, et al. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci USA 2002;99:11328-11333.
42. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC. NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 2003;24:136-143.
43. Pietra G, et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci USA 2003;100:10896-10901.
44. Tomasec P, et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000;287:1031-1033.
45. Cerboni C, Mousavi-Jazi M, Wakiguchi H, Carbone E, Karre K, Soderstrom K. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur J Immunol 2001;31:2926-2935.
46. Ruggeri L, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999;94:333-339.
47. Ruggeri L, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-2100.
48. Karre K. A perfect mismatch. Science 2002;295:2029-2031.
49. Velardi A, Ruggeri L, Moretta A, Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol 2002;23:438-444.
50. Vitale M, et al. NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor. Blood 2005;106:566-571.
51. Semino C, Angelini G, Poggi A, Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 2005;106:609-616.
52. Rendon-Mitchell B, et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 2003;170:3890-3897.
53. Buentke E, et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin - Malassezia-influenced cell interaction. J Invest Dermatol 2002;119:850-857.
54. Borg C, et al. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J Clin Invest 2004;114:379-388.
55. Mocikat R, et al. Natural killer cells activated by MHC class I (low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003;19:561-569.
56. Adam C, et al. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 2005;106:338-344.
57. Byrne P, McGuirk P, Todryk S, Mills KH. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1. Eur J Immunol 2004;34:2579-2588.
58. Borg C, et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004;104:3267-3275.
59. Sivori S, et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumours and dendritic cells. Proc Natl Acad Sci USA 2004;101:10116-10121.
60. Schmidt KN, et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 2004;172:138-143.
61. Pisegna S, Pirozzi G, Piccoli M, Frati L, Santoni A, Palmieri G. p38 MAPK activation controls the TLR3-mediated upregulation of cytotoxicity and cytokine production in human NK cells. Blood 2004;104:4157-4164.
62. Mailliard RB, et al. IL-18-induced CD83+ CCR7+ NK helper cells. J Exp Med 2005;200:941-953.
63. Campbell JJ, et al. Unique subpopulations of CD56+ NK and NKT peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001;166:6477-6482.
64. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 2002;71:173-183.
65. Vitale M, et al. The small subset of CD56bright CD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 2004;34:1715-1722.
66. Kaser A, Kaser S, Kaneider NC, Enrich B, Wiedermann CJ, Tilg H. Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2 through IL-18 receptor expression. Blood 2004;103:648-655.
67. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-640.
68. Ferlazzo G, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004;101:16606-16611.
69. Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 1998;187:1-14.
70. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather P. Natural Killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
71. Dokun AO, Chu DT, Yang L, Bendelac AS, Yokoyama WM. Analysis of in situ NK cell responses during viral infection. J Immunol 2001;167:5286-5293.
72. + cells and murine cytomegalovirus infection: what happens in situ? J Immunol 2001;166:1796-1802.
73. Albertsson PA, et al. NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol 2003;24:603-609.
74. Lande R, et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 2003;170:1174-1182.
75. Ishida Y, et al. The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett 2004;569:156-160.
76. Yoneda O, et al. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. Eur J Immunol 2003;33:53-58.
77. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001;31:3388-3393.
78. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-760.
79. Asselin-Paturel C, Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 2005;202:461-465.
80. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-146.
81. Jinushi M, et al. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 2003;171:5423-5429.
82. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 2003;4:175-181.
83. Supajatura V, et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002;109:1351-1359.
84. Kulka M, et al. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004;114:174-182.
85. Marcenaro E, et al. IL12 or IL4 prime human Natural Killer cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 2005;174:3992-3998.
86. Della Chiesa M, et al. The Tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46 and NKG2D activating receptors and regulates NK cell function. Blood 2006 Aug 10; [Epub ahead of print].
87. Uyttenhove C, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003;9:1269-1274.
88. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004;4:762-774.
89. Ferlazzo G, Munz C. NK cell compartments and their activation by dendritic cells. J Immunol 2004;172:1333-1339.
90. Bajenoff M, et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 2006;203:619-631.
91. Ferlazzo G, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004;172:1455-1462.
92. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003;101:3052-3057.
93. bright subset. Blood 2001;97:3146-3151.
94. Coudert JD, Coureau C, Guéry J-C. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens. J Immunol 2002;169:2979-2987.
95. Combe CL, Curiel TJ, Moretto MM, Khan IA. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Infect Immun 2005;73:4913-4921.
96. Martin-Fontecha A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T (H)1 priming. Nat Immunol 2004;5:1260-1265.
97. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 2004;173:3716-3724.
98. Hanna J, et al. Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 2004;114:1612-1623.
99. Van den Broeke LT, Daschbach E, Thomas EK, Andringa G, Berzofsky JA. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol 2003;171:5842-5852.
100. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000;191:411-416.
101. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001;193:233-238.
102. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000;1:305-310.
103. Gerosa F, et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 2005;174:727-734.
104. Romagnani C, et al. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4(+) T helper cells and CD4(+) CD25(hi) T regulatory cells. Eur J Immunol 2005;35:2452-2458.
105. Colonna M, Trinchieri G, Liu Y-J. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004;5:1219-1226.
106. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005;23:275-306.
107. Barchet W, Blasius A, Cella M, Colonna M. Plasmacytoid dendritic cells: in search of their niche in immune responses. Immunol Res 2005;32:75-84.
108. Fuchs A, Cella M, Kondo T, Colonna M. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 2005;106:2076-2082.
109. Corcoran L, et al. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J Immunol 2003;15:4926-4932.
110. Della Chiesa M, Romagnani C, Thiel A, Moretta L, Moretta A. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 2006 July 27; [Epub ahead of print].
111. Hanabuchi S, et al. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006;107:3617-3623.